Research conferences like the Kidney Cancer Research Summit bring together scientists, clinicians, industry leaders, and patient advocates to share discoveries, exchange ideas, and accelerate progress in #KidneyCancer research.
#AcceleratingCures #KidneyCancerAwarenessMonth
Scientists are exploring new tools and technologies, from biomarkers that could guide personalized treatment, to AI-driven tools that help detect and analyze tumors, to combination therapies designed to improve treatment outcomes.
#AcceleratingCures #KidneyCancerAwarenessMonth
Federal funding supports many of the scientific discoveries that lead to new treatments and improved outcomes. When advocates speak up, they help ensure #KidneyCancer remains a priority for policymakers and research agencies.
Learn more: https://kidneycan.org/restore-kcrp/
#AcceleratingCures
Research drives progress in #KidneyCancer. From scientific collaboration and clinical trials to advocacy that secures critical funding, each step plays a role in improving outcomes for patients.
#AcceleratingCures #KidneyCancerAwarenessMonth
This month, KidneyCAN advocates came together in Washington, D.C. to make #KidneyCancer research a priority. Patients, caregivers, clinicians, and researchers met with lawmakers to push for sustained federal investment in the research that drives new treatments and saves lives.
#AcceleratingCures
Understanding your options — including the goals of treatment, potential side effects, & whether clinical trials may be appropriate — can help you make informed decisions with your care team.
For more resources, visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCanceerAwarenessMonth
Before new therapies become widely available, they are carefully studied in clinical trials. Each phase helps researchers answer questions about safety, effectiveness, & how a treatment should be used.
To learn more: https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
Surgery is often the first treatment used for #KidneyCancer, especially when the tumor is confined to the kidney. Advances in surgical techniques have helped improve recovery & outcomes for many patients.
Learn more at https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
#KCRS26 is designed to maximize scientific exchange in #KidneyCancer research. Oral presentations include dedicated discussion time with a focused audience of investigators and clinicians.
Submit your abstract by May 4, 2026: https://kcrs.kidneycan.org/call-for-abstracts-kcrs26/
#AcceleratingCures
Treatment for #KidneyCancer has advanced significantly in recent years. From surgery to immunotherapy, understanding the full landscape can help patients and families make informed decisions about care.
#AcceleratingCures #KidneyCancerAwarenessMonth #KnowledgeIsPower
This month, we’re highlighting the work of the tRCC Project, which is advancing research for tRCC #KidneyCancer by building a comprehensive dataset that combines clinical information, genomic sequencing, & patient-reported experience.
Learn more: trccproject.org
#AcceleratingCures #BetterTogether
The Kidney Cancer Research Summit returns July 23–24, 2026 at the InterContinental Boston! #KCRS26 brings together leading researchers, clinicians, and industry experts to share new discoveries, exchange ideas, and accelerate progress in kidney cancer research.
#AcceleratingCures
Join Triage Cancer’s upcoming webinar, Steps to Navigate Common Insurance Hurdles, to learn strategies for dealing with issues like prior authorizations, coverage denials, co-pay accumulators, and more.
Register here: https://triagecancer.org/webinarreg-insurance-hurdles
#AcceleratingCures
Understanding what tests were done, what the results mean, and how the cancer is staged can help you feel more confident when discussing next steps with your care team.
For more resources, visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
Understanding the tests used to diagnose kidney cancer can help patients feel more prepared and informed when discussing results and next steps with their care team.
To learn more, visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
The 5th Celebration of Hope: Focus on Kidney Cancer Educational Symposium brings together healthcare professionals, patients, caregivers, and advocates for a day of learning and community.
Register here: https://www.med.upenn.edu/kidney2026/
#AcceleratingCures
Many people with #KidneyCancer don’t experience symptoms right away. When symptoms do occur, they can include blood in the urine, pain in the side or lower back, or unexplained weight loss.
For more information, visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
‼️ The AACR–KidneyCAN Kidney Cancer Innovation and Discovery Grants provide $50,000 in direct research support for one year.
Applications are due TOMORROW, March 12!
Apply here: https://bit.ly/AACR_KC_Grant
#AcceleratingCures
#KidneyCancer can be difficult to detect because many people have few or no symptoms in its early stages. Understanding what to watch for and how kidney cancer is diagnosed can help people seek care sooner and ask the right questions.
#AcceleratingCures #KidneyCancerAwarenessMonth #KnowledgeisPower
KidneyCAN’s Advocacy Days would not be possible without the support of our sponsors.
Their partnership helps bring patients, caregivers, clinicians, and advocates to Capitol Hill to speak directly with lawmakers about the importance of kidney cancer research.
#AcceleratingCures
#ReedOn3!
The McLaughlin family has launched an incredible grassroots fundraiser to support #KidneyCancer research, inspired by Reed McLaughlin, a devoted father, husband, coach, and loyal supporter of everyone around him.
Help them reach their goal! https://bit.ly/ReedOn3
#AcceleratingCures
Today on Capitol Hill, KidneyCAN advocates are sharing the priorities that matter most for the #KidneyCancer community.
Our message is simple: research saves lives, and continued federal investment is essential to accelerate new treatments and cures.
#RestoreTheResearch #AcceleratingCures
Advocacy Days are almost here!
Patients, caregivers, and advocates from across the country will come together to make #KidneyCancer research a priority on Capitol Hill. Conversations will turn into commitments, and voices will turn into action.
We’re ready to keep #AcceleratingCures.
Today, on #InternationalWomensDay, we recognize the women affected by #KidneyCancer, as patients, caregivers, researchers, and advocates.
Thousands of women are diagnosed each year, and outcomes can vary based on stage, access to care, and participation in clinical research.
#AcceleratingCures
Looking for clear, reliable information about #KidneyCancer?
The 5th Celebration of Hope, hosted by Penn Medicine, brings together experts, patients, and caregivers for a full day of education and discussion.
Register here: https://www.med.upenn.edu/kidney2026/
#AcceleratingCures
#KidneyCancer is classified from Stage 1 (confined to the kidney) to Stage 4 (spread to distant parts of the body). Knowing the stage shapes the conversations patients have with their care teams.
For more information, visit www.patients.kidneycan.org.
#AcceleratingCures #KidneyCancerAwarenessMonth
#KidneyCancer risk is influenced by many factors. Understanding risk can help guide conversations with healthcare providers and inform research efforts aimed at prevention and earlier detection.
To learn more, visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
Have new, unpublished #KidneyCancer research to share?
#KCRS26 is prioritizing abstracts featuring original data — especially results from prospective clinical trials!
Deadline: May 4, 2026
Submit here: https://kcrs.kidneycan.org/call-for-abstracts-kcrs26/
#AcceleratingCures
This #KidneyCancerAwarenessMonth, we’re proud to highlight our friends at the tRCC Project. The project is combining clinical data and genomic sequencing with the most important piece of the puzzle: the patient experience.
🔗 Learn more at trccproject.org
#BetterTogether #AcceleratingCures
Clear cell, papillary, and chromophobe RCC are the most common subtypes of #KidneyCancer, but there are several rarer forms as well, including hereditary and genetically driven conditions.
For more information visit https://patients.kidneycan.org/
#AcceleratingCures #KidneyCancerAwarenessMonth
